[Skip to Content]
[Skip to Content Landing]
July 2, 2014

From JAMA’s Daily News Site

Author Affiliations

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2014;312(1):18. doi:10.1001/jama.2014.7685

To help ease an ongoing intravenous (IV) fluid shortage in the United States, the US Food and Drug Administration is allowing Baxter Healthcare Corporation to temporarily import IV saline from its plant in Spain. The agency is also permitting the importation of a saline product from Norway.

Many hospitals and other health care facilities have been taking extraordinary measures to minimize patient harm resulting from the ongoing shortage of IV fluid, such as giving water or alternative fluids rather than IV fluid to patients who were capable of drinking. The hours involved in calling suppliers and managing supplies costs the hospitals valuable staff time.

First Page Preview View Large
First page PDF preview
First page PDF preview